Back to search

Article

Curcumin Inhibition of DYRK Kinases

2024-06-10

Abstract excerpt

Curcumin is known as a dietary supplement with several health benefits, including antioxidant, blood sugar-lowering, anti-inflammatory, and anti-cancer properties. These benefits make it useful in the treatment of diabetes, neurodegenerative diseases, and cancer. This research focuses on how curcumin interacts with dual-specificity tyrosine-regulated kinases (DYRKs), particularly DYRK1A and DYRK2, which control im...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
18761c77-12eb-5b2c-a5e1-0a635c60c6bb
DOI
10.1101/2024.06.10.598318
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Curcumin Inhibition of DYRK KinasesDOI 10.1101/2024.06.10.598318
A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replicationSemantic proximity
DYRK1A Kinase Inhibitors with Emphasis on CancerSemantic proximity
Emerging roles of DYRK2 in cancerSemantic proximity
Pharmacologic and genetic approaches define human pancreatic β cell mitogenic targets of DYRK1A inhibitorsSemantic proximity
The DYRK Family of Kinases in Cancer: Molecular Functions and Therapeutic OpportunitiesSemantic proximity
Leucine-rich repeat kinase 2 at a glance.Semantic proximity
DYRK1A Inhibitors and Perspectives for the Treatment of Alzheimer's DiseaseSemantic proximity
DYRK1A kinase inhibition with emphasis on neurodegeneration: A comprehensive evolution story-cum-perspectiveSemantic proximity
An ELISA DYRK1A non-radioactive kinase assay suitable for the characterization of inhibitorsSemantic proximity
The Omnipresence of DYRK1A in Human DiseasesSemantic proximity
Identification of a DYRK1A Inhibitor that Induces Degradation of the Target Kinase using Co-chaperone CDC37 fused with Luciferase nanoKAZ.Semantic proximity
Down syndrome and DYRK1A overexpression: relationships and future therapeutic directionsSemantic proximity
Select a neighboring publication to make it the new centre.